This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Old Republic International (ORI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of +52.05% and +1.90%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
EVER Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
EverQuote remains poised to gain from its exclusive data asset and technology, intensified focus on core P&C markets and strong financial profile.
Here's Why Investors Should Hold CNO Financial Stock for Now
by Zacks Equity Research
CNO's growth is fueled by rising premiums, tech investments and acquisitions, though high leverage and costs pose challenges.
AIZ Trades Above 200-Day SMA: Time to Add it for Better Returns?
by Zacks Equity Research
Assurant rides on growth in capital-light businesses, Connected Living, and Global Housing, supported by solid cash flow and strategic capital deployment.
Prudential (PRU) Up 5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Prudential (PRU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO (CNO) Up 6.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Radian Outperforms Industry, Trades at Discount: How to Play the Stock
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
EverQuote Trades Above 200-Day SMA: Time to Buy the Stock?
by Zacks Equity Research
EVER trades above its 200-day SMA with strong returns and rising quote requests, though challenges remain ahead.
CNO Q2 Earnings Beat Estimates on Strong Annuity Collected Premiums
by Zacks Equity Research
CNO Financial's Q2 earnings benefit from growth in annuity and health premiums, and rising fee income, partly offset by an elevated expense level. It still expects 2025 operating EPS within $3.70-$3.90.
Compared to Estimates, CNO (CNO) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for CNO (CNO) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CNO Financial (CNO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of +2.35% and +19.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Prudential (PRU) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Prudential (PRU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: CNO Financial (CNO) Q2 Earnings Expected to Decline
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in CNO Financial Stock?
by Zacks Equity Research
Investors need to pay close attention to CNO stock based on the movements in the options market lately.
EVER Rallies 27% YTD, Trades at Premium: Should You Buy the Stock?
by Zacks Equity Research
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
AIZ Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Assurant rides on growth in capital-light businesses, Connected Living, and Global Housing, supported by solid cash flow and strategic capital deployment.
Why Is Radian (RDN) Up 5.2% Since Last Earnings Report?
by Zacks Equity Research
Radian (RDN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is CNO (CNO) Up 0.5% Since Last Earnings Report?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MTG Near 52-Week High: Time to Buy the Stock for Solid Returns?
by Zacks Equity Research
MGIC Investment gains from new business, solid annual persistency, higher level of home sales, effective capital deployment and sufficient liquidity.
CNO Q1 Earnings Meet Estimates on Higher Collected Premiums
by Zacks Equity Research
CNO affirms operating EPS to be in the range of $3.70-$3.90 and excess cash flow in the range of $200-$250 million.
Is a Beat in the Cards for Palomar This Earnings Season?
by Zacks Equity Research
PLMR's first-quarter earnings are likely to have benefited from its fee-based revenue stream.
CNO (CNO) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for CNO (CNO) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CNO Financial (CNO) Q1 Earnings Meet Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 0% and 5.15%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Prudential Financial Q1 Earnings Coming Up: What to Expect
by Zacks Equity Research
PRU's Q1 results are likely to better results across its segments, offset by higher expenses.
Hanover Insurance Set to Report Q1 Earnings: What to Expect
by Zacks Equity Research
THG's Q1 results are likely to reflect a reduction in Personal Lines policy count in the Midwest and the implementation of deductibles in most of Personal Lines.